CUSIP No. 15089R102
|
SCHEDULE 13G
|
Page 2 of 11 Pages
|
1
|
NAMES OF REPORTING PERSONS
Quaker BioVentures, L.P.
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
|
6
|
SHARED VOTING POWER*
1,345,400
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
1,345,400
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,345,400
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9**
5.2%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
*
|
Includes 58,126 shares issuable upon exercise of a warrant to purchase the Issuer’s common stock.
|
**
|
Based on 26,026,793 shares of the Issuer’s common stock issued and outstanding as of November 6, 2013, as reported in the Issuer’s quarterly report on Form 10-Q filed with the Securities Exchange Commission (the “SEC”) on November 12, 2013.
|
CUSIP No. 15089R102
|
SCHEDULE 13G
|
Page 3 of 11 Pages
|
1
|
NAMES OF REPORTING PERSONS
Garden State Life Sciences Venture Fund, L.P.
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
|
6
|
SHARED VOTING POWER*
658,072
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
658,072
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
658,072
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9**
2.5%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
*
|
Includes 67,645 shares issuable upon exercise of a warrant to purchase the Issuer’s common stock.
|
**
|
Based on 26,026,793 shares of the Issuer’s common stock issued and outstanding as of November 6, 2013, as reported in the Issuer’s quarterly report on Form 10-Q filed with the SEC on November 12, 2013.
|
CUSIP No. 15089R102
|
SCHEDULE 13G
|
Page 4 of 11 Pages
|
1
|
NAMES OF REPORTING PERSONS
Quaker BioVentures Capital, L.P.
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
|
6
|
SHARED VOTING POWER*
2,003,472
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
2,003,472
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,003,472
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9**
7.7%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
*
|
Includes 125,771 shares issuable upon exercise of a warrant to purchase the Issuer’s common stock.
|
**
|
Based on 26,026,793 shares of the Issuer’s common stock issued and outstanding as of November 6, 2013, as reported in the Issuer’s quarterly report on Form 10-Q filed with the SEC on November 12, 2013.
|
CUSIP No. 15089R102
|
SCHEDULE 13G
|
Page 5 of 11 Pages
|
1
|
NAMES OF REPORTING PERSONS
Quaker BioVentures Capital, LLC
|
||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
(a) o
(b) o
|
||
3
|
SEC USE ONLY
|
||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
|
||
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
|
5
|
SOLE VOTING POWER
0
|
|
6
|
SHARED VOTING POWER*
2,003,472
|
||
7
|
SOLE DISPOSITIVE POWER
0
|
||
8
|
SHARED DISPOSITIVE POWER
2,003,472
|
||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,003,472
|
||
10
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
o
|
||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9**
7.7%
|
||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
PN
|
*
|
Includes 125,771 shares issuable upon exercise of a warrant to purchase the Issuer’s common stock.
|
**
|
Based on 26,026,793 shares of the Issuer’s common stock issued and outstanding as of November 6, 2013, as reported in the Issuer’s quarterly report on Form 10-Q filed with the SEC on November 12, 2013.
|
CUSIP No. 15089R102
|
SCHEDULE 13G
|
Page 6 of 11 Pages
|
Item 1(a)
|
Name of Issuer:
Celator Pharmaceuticals, Inc.
|
Item 1(b)
|
Address of Issuer’s Principal Executive Offices:
200 Princeton South Corporate Drive, Suite 180
Ewing, NJ 08628
|
Item 2(a)
|
Name of Person Filing:
Quaker BioVentures, L.P.
Garden State Life Sciences Venture Fund, L.P.
Quaker BioVentures Capital, L.P.
Quaker BioVentures Capital, LLC
|
Item 2(b)
|
Address of Principal Business Office or, if none, Residence:
The address of the principal business office of each of the Reporting Persons is 2929 Arch Street, Cira Centre, Philadelphia, PA 19104-2868.
|
Item 2(c)
|
Citizenship:
Quaker BioVentures, L.P. – Delaware
Garden State Life Sciences Venture Fund, L.P. – Delaware
Quaker BioVentures Capital, L.P. – Delaware
Quaker BioVentures Capital, LLC – Delaware
|
Item 2(d)
|
Title of Class of Securities:
Common Stock, $0.001 par value per share
|
Item 2(e)
|
CUSIP Number:
15089R102
|
Item 3
|
Not applicable.
|
Item 4
|
Ownership.
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
Quaker BioVentures, L.P. – 1,345,400
Garden State Life Sciences Venture Fund, L.P. – 658,072
Quaker BioVentures Capital, L.P. – 2,003,472
Quaker BioVentures Capital, LLC – 2,003,472
|
CUSIP No. 15089R102
|
SCHEDULE 13G
|
Page 7 of 11 Pages
|
(b) Percent of class:
Quaker BioVentures, L.P. – 5.2%
Garden State Life Sciences Venture Fund, L.P. – 2.5%
Quaker BioVentures Capital, L.P. – 7.7%
Quaker BioVentures Capital, LLC – 7.7%
(c) Number of shares as to which the person has:
(i)Sole power to vote or to direct the vote
Quaker BioVentures, L.P. – 0
Garden State Life Sciences Venture Fund, L.P. – 0
Quaker BioVentures Capital, L.P. – 0
Quaker BioVentures Capital, LLC – 0
(ii)Shared power to vote or to direct the vote
Quaker BioVentures, L.P. – 1,345,400
|
|
Garden State Life Sciences Venture Fund, L.P. – 658,072
Quaker BioVentures Capital, L.P. – 2,003,472
|
|
Quaker BioVentures Capital, LLC – 2,003,472
(iii)Sole power to dispose or to direct the disposition of
Quaker BioVentures, L.P. – 0
Garden State Life Sciences Venture Fund, L.P. – 0
Quaker BioVentures Capital, L.P. – 0
Quaker BioVentures Capital, LLC – 0
(iv)Shared power to dispose or to direct the disposition of
Quaker BioVentures, L.P. – 1,345,400
Garden State Life Sciences Venture Fund, L.P. – 658,072
Quaker BioVentures Capital, L.P. – 2,003,472
Quaker BioVentures Capital, LLC – 2,003,472
The beneficial ownership amounts disclosed above include (i) 58,126 shares issuable upon exercise of a warrant to purchase the Issuer’s common stock held by Quaker BioVentures, L.P.; and (ii) 67,645 shares issuable upon exercise of a warrant to purchase the Issuer’s common stock held by Garden State Life Sciences Venture Fund, L.P. Quaker BioVentures Capital, L.P. is the general partner of each of Quaker BioVentures, L.P. and Garden State Life Sciences Venture Fund, L.P., and Quaker BioVentures Capital, LLC is the general partner of Quaker BioVentures Capital, L.P.
|
|
Item 5
|
Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following o.
|
Item 6
|
Ownership of More than Five Percent on Behalf of Another Person.
Not applicable.
|
Item 7
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not applicable.
|
CUSIP No. 15089R102
|
SCHEDULE 13G
|
Page 8 of 11 Pages
|
Item 8
|
Identification and Classification of Members of the Group.
Each of the Reporting Persons may be deemed to be a member of a group with respect to the issuer or securities of the issuer for the purpose of Section 13(d) or 13(g) of the Securities Exchange Act of 1934, as amended.
|
Item 9
|
Notice of Dissolution of Group.
Not applicable.
|
Item 10
|
Certification.
Not applicable.
|
CUSIP No. 15089R102
|
SCHEDULE 13G
|
Page 9 of 11 Pages
|
Date: February 13, 2014
|
QUAKER BIOVENTURES, L.P.
By: Quaker BioVentures Capital, L.P., its general partner
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Managing Member
|
GARDEN STATE LIFE SCIENCES VENTURE FUND, L.P.
By: Quaker BioVentures Capital, L.P., its general partner
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Managing Member
|
|
QUAKER BIOVENTURES CAPITAL, L.P.
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Managing Member
|
|
QUAKER BIOVENTURES CAPITAL, LLC
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Managing Member
|
CUSIP No. 15089R102
|
SCHEDULE 13G
|
Page 10 of 11 Pages
|
Date: February 13, 2014
|
QUAKER BIOVENTURES, L.P.
By: Quaker BioVentures Capital, L.P., its general partner
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Managing Member
|
GARDEN STATE LIFE SCIENCES VENTURE FUND, L.P.
By: Quaker BioVentures Capital, L.P., its general partner
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Managing Member
|
|
QUAKER BIOVENTURES CAPITAL, L.P.
By: Quaker BioVentures Capital, LLC, its general partner
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Managing Member
|
CUSIP No. 15089R102
|
SCHEDULE 13G
|
Page 11 of 11 Pages
|
QUAKER BIOVENTURES CAPITAL, LLC
/s/ Richard S. Kollender
Name: Richard S. Kollender
Title: Managing Member
|